This application requests support for the third cycle of this program project that has been dedicated to the development of gene therapy for cardiovascular diseases. We plan in this cycle to focus on the pre-clinical development of gene therapy to liver for the treatment of two severe dyslipidemias: familial hypercholesterolemia (FH) and abetalipoproteinemia (ABL). In studies performed during the current cycle of this grant we developed a number of vectors based on novel adeno-associated viruses (AAV). We showed that many of these have substantially improved performance profiles in terms of gene transfer efficiency, safety and immunogenicity. The goal of this application is to identify the optimal AAV vector for liver directed gene therapy and to study areas of vector biology relevant for the potential testing of these vectors in humans. The feasibility of treating FH and ABL will be assessed in relevant animal models. Key milestones are identification of the clinical candidate vector in year one and the development of sufficient pre-clinical data at the end of year 5 to proceed with phase I clinical trials in both FH and/or ABL in a subsequent application. Project I, directed by Dr. J. Wilson, will develop the clinical candidate vector and will evaluate key issues of vector immunology relevant to safety and efficacy. Project II, directed by Dr. D. Rader, will perform all pre-clincal studies of gene therapy in animals models of FH (mice, rabbits and monkeys) and ABL (mice). Project III, directed by Dr. G. Gao, will evaluate the molecular biology of AAV in liver in terms of recombination with endogenous virus, integration and oncogenicity. The Projects will be supported by three scientific cores - Vector (Core A), Cell Morphology (Core B), and Animal Models (Core C) - and the Administrative Core (Core D). Lay abstract. This project will use a novel viral vector system based on adeno-associated viral vectors (AAV) to develop gene therapy for two very severe inherited forms of lipid metabolism called: familial hypercholesterolemia (FH) and abetalipoproteinemia (ABL). The grant will do all pre-clinical studies necessary to begin clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL059407-15
Application #
8502513
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Mcdonald, Cheryl
Project Start
2000-05-15
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
15
Fiscal Year
2013
Total Cost
$1,798,007
Indirect Cost
$517,417
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ibrahim, Salam; Somanathan, Suryanarayan; Billheimer, Jeffrey et al. (2016) Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol. Cardiovasc Res 110:23-9
Ajufo, Ezim; Cuchel, Marina (2016) Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia. Curr Atheroscler Rep 18:22
Rashnonejad, Afrooz; Chermahini, Gholamhossein Amini; Li, Shaoyong et al. (2016) Large-Scale Production of Adeno-Associated Viral Vector Serotype-9 Carrying the Human Survival Motor Neuron Gene. Mol Biotechnol 58:30-6
Halder, Sujata; Van Vliet, Kim; Smith, J Kennon et al. (2015) Structure of neurotropic adeno-associated virus AAVrh.8. J Struct Biol 192:21-36
Xie, Jun; Burt, Daniel Robert; Gao, Guangping (2015) Adeno-associated virus-mediated microRNA delivery and therapeutics. Semin Liver Dis 35:81-8
Bissig-Choisat, Beatrice; Wang, Lili; Legras, Xavier et al. (2015) Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nat Commun 6:7339
Wang, Lili; Bell, Peter; Somanathan, Suryanarayan et al. (2015) Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids. Mol Ther 23:1877-87
Wang, Qiang; Lock, Martin; Prongay, Andrew J et al. (2015) Identification of an adeno-associated virus binding epitope for AVB sepharose affinity resin. Mol Ther Methods Clin Dev 2:15040
Ahmed, Seemin S; Gao, Guangping (2015) Making the White Matter Matters: Progress in Understanding Canavan's Disease and Therapeutic Interventions Through Eight Decades. JIMD Rep 19:11-22
Wang, Dan; Gao, Guangping (2014) State-of-the-art human gene therapy: part I. Gene delivery technologies. Discov Med 18:67-77

Showing the most recent 10 out of 140 publications